The Land That Doesn’t Need Ozempic || by Johann Hari :: TIME

"In March 2023, the Japanese medical authorities announced that the new weight loss drug Wegovy—which was in staggering demand across the world, causing shortages everywhere—had been approved to treat obesity in their country......But industry outlet the Pharma Letter explained that this would not in fact turn out to be much of a boost........ for a simple reason: there is almost no obesity there. Some 42% of Americans are obese, compared with just 4.5% of Japanese people."  More at TIME ➜